Showing results (31-40 of 411) with videos related to

Sort By:
Pageof 42
Cancer Treatment Reviews|November 21, 2017
PD-1 blockade in advanced NSCLC: A focus on pembrolizumabSolange Peters, Keith M Kerr, Rolf Stahel
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|July 20, 2017
Feasibility of advanced practice nursing in lung cancer consultations during early treatment: A phase II studyAndrea Serena, Andrew Dwyer, Solange Peters, et al.
Cancer Treatment Reviews|March 29, 2016
The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancerSolange Peters, Christin Bexelius, Veronica Munk, et al.
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysisUrania Dafni, Zoi Tsourti, Katerina Vervita, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 13, 2012
Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancerAntonio Passaro, Daniele Alesini, Alessia Pochesci, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|July 24, 2018
Acceptance of the Advanced Practice Nurse in Lung Cancer Role by Healthcare Professionals and Patients: A Qualitative ExplorationAndrea Serena, Andrew A Dwyer, Solange Peters, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Immune Checkpoint Inhibitors in the Management of Lung CancerStefan Zimmermann, Solange Peters, Taofeek Owinokoko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2019
Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung CancerPablo Martinez, Solange Peters, Timothy Stammers, et al.
Expert Review of Anticancer Therapy|April 27, 2013
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectivesJames A Lee, Lukas Bubendorf, Rolf Stahel, et al.
Pageof 42